Cargando…
COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger?
Autor principal: | Hoption Cann, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884605/ https://www.ncbi.nlm.nih.gov/pubmed/38013776 http://dx.doi.org/10.1016/j.imj.2023.01.004 |
Ejemplares similares
-
Antipyretics and vaccine‐induced myocarditis
por: Hoption Cann, Stephen A.
Publicado: (2023) -
Fever: Could A Cardinal Sign of COVID-19 Infection Reduce Mortality?
por: Cann, Stephen A Hoption
Publicado: (2021) -
Postvaccine myocarditis and the use of antipyretics: Is there any relation?
por: Fatima, Maurish, et al.
Publicado: (2023) -
Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines?
por: Etminan, Mahyar, et al.
Publicado: (2021) -
Misuse of Antipyretic Amid Fear of COVID-19 Vaccine
por: Gautam, Arun, et al.
Publicado: (2022)